1. Home
  2. OKE vs SNN Comparison

OKE vs SNN Comparison

Compare OKE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OKE
  • SNN
  • Stock Information
  • Founded
  • OKE 1906
  • SNN 1856
  • Country
  • OKE United States
  • SNN United Kingdom
  • Employees
  • OKE N/A
  • SNN N/A
  • Industry
  • OKE Oil & Gas Production
  • SNN Industrial Specialties
  • Sector
  • OKE Utilities
  • SNN Health Care
  • Exchange
  • OKE Nasdaq
  • SNN Nasdaq
  • Market Cap
  • OKE N/A
  • SNN 12.4B
  • IPO Year
  • OKE N/A
  • SNN 1999
  • Fundamental
  • Price
  • OKE $97.29
  • SNN $29.44
  • Analyst Decision
  • OKE Buy
  • SNN Strong Buy
  • Analyst Count
  • OKE 16
  • SNN 1
  • Target Price
  • OKE $93.60
  • SNN N/A
  • AVG Volume (30 Days)
  • OKE 2.4M
  • SNN 674.7K
  • Earning Date
  • OKE 10-29-2024
  • SNN 08-01-2024
  • Dividend Yield
  • OKE 4.07%
  • SNN 2.55%
  • EPS Growth
  • OKE N/A
  • SNN 39.77
  • EPS
  • OKE 4.62
  • SNN 0.35
  • Revenue
  • OKE $19,099,000,000.00
  • SNN $5,642,000,000.00
  • Revenue This Year
  • OKE $26.50
  • SNN $6.92
  • Revenue Next Year
  • OKE $11.02
  • SNN $5.43
  • P/E Ratio
  • OKE $21.05
  • SNN $41.81
  • Revenue Growth
  • OKE N/A
  • SNN 5.48
  • 52 Week Low
  • OKE $63.33
  • SNN $21.53
  • 52 Week High
  • OKE $98.43
  • SNN $31.72
  • Technical
  • Relative Strength Index (RSI)
  • OKE 60.50
  • SNN 46.87
  • Support Level
  • OKE $94.53
  • SNN $28.26
  • Resistance Level
  • OKE $98.43
  • SNN $29.64
  • Average True Range (ATR)
  • OKE 1.48
  • SNN 0.36
  • MACD
  • OKE 0.05
  • SNN 0.05
  • Stochastic Oscillator
  • OKE 72.50
  • SNN 58.65

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: